SURMOUNT-2: Tirzepatide achieved up to 15.7% weight lossSeventy-two week outcomes from the SURMOUNT-2 trial has revealed that tirzepatide (10mg and 15mg) achieved superior weight loss compared...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour1 day ago